NASDAQ: ABVX - ABIVAX Société Anonyme

Yield per half year: -36.84%
Sector: Healthcare

Share chart ABIVAX Société Anonyme

Extended chart Simple chart
Financial Markets by TradingView

About

ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

EBITDA -0.0333
EV/EBITDA -0.3297
IPO date 2023-10-20
ISIN US00370M1036
Industry Biotechnology
P/BV 2.13
P/S 90.21
Sector Health Care
Валюта usd
Валюта отчета eur
Выручка 2.3E-5
Сайт https://www.abivax.com
Цена ао 10.29
Число акций ао 0.04307 млрд
Change price per day: -5.54% (10.29)
Change price per week: -16.21% (11.6)
Change price per month: -21.3% (12.35)
Change price per 3 month: -26.59% (13.24)
Change price per half year: -36.84% (15.39)
Change price per year to date: +7.4% (9.05)
All parameters

Underestimation

Title Value Grade
P/S 90.21 1
P/BV 2.13 7
P/E 0 0
EV/EBITDA -1.68 0
Total: 3.88

Efficiency

Title Value Grade
ROA, % -45.17 0
ROE, % -75.37 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.4212 10
Total: 9.6

Growth impulse

Title Value Grade
Yield Revenue, % 19991.3 10
Yield Ebitda, % 294.32 10
Yield EPS, % -50.72 0
Total: 8
More

Institutions Volume Share, %
Franklin Resources, Inc. 1249295 1.99
Financial Management Professionals, Inc. 100 0

ETF Share, % Profitability for 1 year, % Dividends, %
Xtrackers MSCI Eurozone Hedged Equity ETF 0.00503 13.143762633194 3.86046
SPDR Portfolio Europe ETF 0.00252 8.9403102813568 3.66537



Head Job title Payment Year of birth
Dr. Philippe Pouletty M.D., Ph.D. Founder & Director N/A 1958 (66 years)
Mr. Marc M. P. de Garidel M.B.A. CEO & Director 858.61k 1958 (66 years)
Mr. Didier Blondel EVP, CFO & Board Secretary N/A 1964 (60 years)
Mr. Didier Scherrer Ph.D. Chief Scientific Officer N/A 1970 (54 years)
Mr. Patrick Malloy Senior Vice President of Investor Relations N/A
Ms. Ida Hatoum Chief People & Compliance Officer N/A 1975 (49 years)
Mr. Pierre Courteille M.B.A. Chief Business Officer N/A 1969 (55 years)
Mr. Michael Ferguson B.S., M.B.A. Chief Commercial Officer N/A 1978 (46 years)
Mr. Jerome Denis Ph.D. Executive Vice President of Process Development & Manufacturing
Ms. Ana Sharma M.P.H. VP & Global Head of Quality

Address: France, Paris, 7-11 boulevard Haussmann - open in Google maps, open in Yandex maps
Website: https://www.abivax.com